The earnings call indicates strong revenue growth, profitability, and cash flow achievements, with a robust increase in procedure volumes and physician engagement. While there are some challenges such as delayed regulatory clearance in Europe and expected cash usage in the second half, the positive aspects significantly outweigh the negatives.

Company Guidance -

Q3 2025

During the SI-BONE Second Quarter 2025 Earnings Conference Call, the company provided extensive guidance on its financial outlook and strategic priorities. SI-BONE reported worldwide revenue of $48.6 million, reflecting a growth of 21.7% compared to the prior year, with U.S. revenue increasing by 22.8%. The company achieved its third consecutive quarter of positive adjusted EBITDA, amounting to $1 million, and reached a significant cash flow milestone by achieving breakeven during the quarter. SI-BONE updated its full-year revenue guidance to a range of $195 million to $198 million, implying a year-over-year growth of approximately 17% to 18%. Gross margin for the quarter expanded by 80 basis points to 79.8%, and the company adjusted its full-year gross margin guidance to be between 78.5% and 79%. Key growth drivers included a 25% increase in U.S. procedure volumes and the successful international launch of iFuse TORQ in Europe. SI-BONE continues to focus on innovation, with plans to introduce new products targeting over 0.5 million annual procedures in the U.S., while also expanding its surgeon base, which saw a 25% increase to 1,440 U.S. physicians. The company’s strategic priorities include product innovation, commercial execution, and operational excellence, aimed at sustaining growth and profitability.

Record U.S. Revenue Growth

U.S. revenue grew approximately 23%, supported by a 25% increase in procedure volumes, reaffirming robust underlying demand across target markets.

Continued Profitability and Cash Flow Breakeven

Third consecutive quarter of positive adjusted EBITDA and achieving cash flow breakeven ahead of the original timeline.

Strong Physician Engagement

A record 1,440 U.S. physicians performed procedures, representing a 25% increase over the prior year period.

Successful International Launch

The launch of iFuse TORQ in Europe is expected to accelerate growth across international markets.

Gross Margin Expansion

Gross margin was 79.8%, expanding by 80 basis points year-over-year, driven by improved manufacturing and supply chain efficiencies.

SI-Bone (SIBN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SIBN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.17 / -	-0.16	―	―	―
Aug 04, 2025	2025 (Q2)	-0.18 / -0.14	-0.22	36.36% (+0.08)
May 05, 2025	2025 (Q1)	-0.23 / -0.15	-0.27	44.44% (+0.12)
Feb 24, 2025	2024 (Q4)	-0.14 / -0.11	-0.27	59.26% (+0.16)
Nov 12, 2024	2024 (Q3)	-0.24 / -0.16	-0.25	36.00% (+0.09)
Aug 05, 2024	2024 (Q2)	-0.28 / -0.22	-0.3	26.67% (+0.08)
May 06, 2024	2024 (Q1)	-0.31 / -0.27	-0.32	15.62% (+0.05)
Feb 26, 2024	2023 (Q4)	-0.28 / -0.27	-0.32	15.62% (+0.05)
Nov 06, 2023	2023 (Q3)	-0.34 / -0.25	-0.41	39.02% (+0.16)
Aug 07, 2023	2023 (Q2)	-0.40 / -0.30	-0.54	44.44% (+0.24)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SIBN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 04, 2025	$17.90	$16.00	-10.61%
May 05, 2025	$14.25	$16.45	+15.44%
Feb 24, 2025	$17.47	$18.44	+5.55%
Nov 12, 2024	$15.63	$13.14	-15.93%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Si-Bone (SIBN) report earnings?

Si-Bone (SIBN) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is Si-Bone (SIBN) earnings time?

Si-Bone (SIBN) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SIBN EPS forecast?

SIBN EPS forecast for the fiscal quarter 2025 (Q3) is -0.17.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing